Virtus ETF Advisers’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.21M Buy
37,574
+1,344
+4% +$56.4K 0.85% 22
2026
Q1
$1.17M Hold
36,230
0.54% 32
2025
Q4
$1.53M Hold
36,230
0.72% 24
2025
Q3
$1.24M Hold
36,230
0.69% 32
2025
Q2
$979K Hold
36,230
0.6% 36
2025
Q1
$1.07M Buy
+36,230
New +$1.38M 0.7% 27

Other funds holding VCYT

Virtus ETF Advisers's VCYT Position: Q2 2026 in Review

Virtus ETF Advisers increased its Veracyte (VCYT) stake by 3.7% in Q2 2026, buying an estimated $56.4K and bringing the position to 37,574 shares worth $2.21M. The position accounts for 0.85% of the portfolio, ranked #22.

Virtus ETF Advisers first reported a position in VCYT in Q1 2025 and has held it in 6 quarters since. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Virtus ETF Advisers held 37,574 shares of Veracyte worth $2.21M as of Q2 2026.
  • Virtus ETF Advisers bought 1,344 Veracyte shares in Q2 2026, an estimated $56.4K.
  • Veracyte made up 0.85% of Virtus ETF Advisers's portfolio in Q2 2026, its #22 holding.
  • Virtus ETF Advisers first reported a position in Veracyte in Q1 2025 and has held it in 6 quarters since.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.